Post-market surveillanceAndrogen Modulator
Compound 61731
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061731
Risk Class
MODERATE
Last Audit
Jul 4, 2108
Research Abstract
Androgen Modulator candidate engineered for cognitive resilience initiatives with automated dossier coverage.
Compound 61731 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for cognitive resilience and neuroprotection.
The dossier currently sits in post-market surveillance with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061731 with updates logged 2108-07-04.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cognitive resilienceNeuroprotection
Nomenclature
CX-61731Androgen Modulator Program 61731
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061731
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61731